CSF2 and acute myeloid leukemia: Cytokine-mediated effects by granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and others also contribute to therapy resistance of FLT3-ITD-mutated AML [64].